Combination antiretroviral therapy, also known as cART, is reportedly a state-of-the-art treatment for HIV. Research on cART and its effects on individuals living with HIV is ongoing, with studies examining its long-term impact on health outcomes, including vascular diseases and inflammation. The treatment's relationship to other medical conditions and therapies, such as cancer and thalassemia, is also being explored.